Cargando…
Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure
BACKGROUND: Hyperbaric oxygen therapy (HBOT) has been proposed to address COVID-19- associated respiratory failure. However, its biochemical effects are poorly known. METHOD: 50 patients with hypoxemic COVID-19 pneumonia were divided into C group (standard care) and H group (standard care plus HBOT)...
Autores principales: | Keller, Guillermo A., Colaianni, Ivana, Coria, Javier, Di Girolamo, Guillermo, Miranda, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927797/ https://www.ncbi.nlm.nih.gov/pubmed/36796547 http://dx.doi.org/10.1016/j.rmed.2023.107155 |
Ejemplares similares
-
ROX index to predict CPAP outcome in hypoxemic respiratory failure due to COVID-19
por: Colaianni-Alfonso, Nicolás, et al.
Publicado: (2022) -
Evaluation of Oxygen Saturation Index Compared With Oxygenation Index in Neonates With Hypoxemic Respiratory Failure
por: Muniraman, Hemananda K., et al.
Publicado: (2019) -
Accuracy of Nasal Pressure Swing to Predict Failure of High-Flow Nasal Oxygen in Patients with Acute Hypoxemic Respiratory Failure
por: Tonelli, Roberto, et al.
Publicado: (2022) -
An Unusual Suspect Causing Hypoxemic Respiratory Failure
por: Aqeel, Masooma, et al.
Publicado: (2017) -
Hypoxemic Respiratory Failure: Evidence, Indications, and Exclusions
por: Abrams, Darryl, et al.
Publicado: (2015)